Dubuisson Annie S, Beckers Albert, Stevenaert Achille
Department of Neurosurgery, University Hospital of Liège, Liège, Belgium.
Clin Neurol Neurosurg. 2007 Jan;109(1):63-70. doi: 10.1016/j.clineuro.2006.01.006. Epub 2006 Feb 20.
We retrospectively analysed the incidence, clinical presentation, endocrinological and radiological findings, medical and surgical management of pituitary apoplexy in our department (single-centre study), having a large experience in pituitary surgery. Among 1540 pituitary lesions, 24 patients presented with pituitary apoplexy. Their charts were retrospectively reviewed. The symptoms included headache (92%), nausea and vomiting (54%), visual deficit (50%), oculomotor paresis (54%) and/or an altered mental state (42%). Skull X-rays (n = 14) demonstrated an enlarged sella turcica in all cases; CT-scan and/or MRI always revealed a sellar and suprasellar expanding lesion. Panhypopituitarism was present on admission in 70% of the patients. Urgent therapeutic management included high-dose cortisone treatment in all but one patients and CSF drainage in three. Three patients were treated conservatively. Nine patients were operated on rapidly, within hours or a few days because of severe visual deficit and/or altered level of consciousness. Nineteen patients were operated by the trans-sphenoidal approach; one of them required a second operation by craniotomy. There were two deaths related to the illness and one to an ill-defined reason at 4 months. Among the other patients 95% made a good recovery. All but two patients required a substitutive treatment with adrenal (83%), thyroid (68%), gonadal (42%) and/or growth (16%) hormones. The preoperative visual deficits recovered in all but one patients (92%) whereas the oculomotor pareses improved in all but two patients (85%). In conclusion, pituitary tumour apoplexy is a rare event, complicating in our series 1.6% of 1540 pituitary adenomas. Even in severe cases, complete recovery is possible if the diagnosis is rapidly obtained and adequate management is initiated in time. Surgical results after trans-sphenoidal approach are in the majority of cases very satisfactory.
我们对本科室(单中心研究)垂体卒中的发病率、临床表现、内分泌及影像学检查结果、内科及外科治疗进行了回顾性分析,本科室在垂体手术方面经验丰富。在1540例垂体病变中,24例患者发生垂体卒中。对他们的病历进行了回顾性研究。症状包括头痛(92%)、恶心呕吐(54%)、视力障碍(50%)、动眼神经麻痹(54%)和/或精神状态改变(42%)。14例患者的颅骨X线检查均显示蝶鞍增大;CT扫描和/或MRI始终显示鞍内及鞍上有占位性病变。70%的患者入院时存在全垂体功能减退。紧急治疗措施包括除1例患者外所有患者均接受大剂量皮质激素治疗,3例患者进行脑脊液引流。3例患者接受保守治疗。9例患者因严重视力障碍和/或意识水平改变在数小时或数天内迅速接受手术。19例患者采用经蝶窦入路手术;其中1例患者需要开颅二次手术。有2例患者因病死亡,1例在4个月时死因不明。其他患者中95%恢复良好。除2例患者外,所有患者均需要肾上腺(83%)、甲状腺(68%)、性腺(42%)和/或生长激素(16%)替代治疗。除1例患者外,所有患者术前视力障碍均恢复(92%),除2例患者外,所有患者动眼神经麻痹均改善(85%)。总之,垂体肿瘤卒中是一种罕见事件,在我们的系列研究中,1540例垂体腺瘤中有1.6%发生并发症。即使在严重病例中,如果能迅速做出诊断并及时采取适当治疗,也有可能完全康复。经蝶窦入路手术的效果在大多数情况下非常令人满意。